Clinical Pathways Search Results

This pathway provides guidance for identifying neonates symptomatic at or near the time of birth from Hypoxic-Ischemic Encephalopathy (HIE) who may be eligible whole body cooling.

Inpatient and outpatient medical and surgical management for pediatric preseptal or orbital cellulitis patients

The Gastroenteritis Pathway is intended to guide inpatient evaluation and management of dehydration secondary to gastroenteritis in the pediatric patient.

The dental emergency pathway is meant to guide providers on the necessary steps in the evaluation and treatment of emergent dental pathology and/or trauma in the emergency department.

Clinical Pathway for Inpatient Recommendations for SARS-CoV-2 Testing provides guidance for the evaluation and care of patients with suspected coronavirus (SARS-CoV-2).

This pathway should be used to guide the evaluation and treatment of patients with fever and recent travel. ≥ 38 °C in a traveler within 30 days of return to the U.S.

This pathway guides the care of children who present with onset of flaccid weakness in one or more extremities +/- bulbar/cranial nerve findings without other clear cause. 

The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.

The unprovoked seizure clinical pathway outlines the steps to standardize the ED clinical assessment, evaluation and recommend Neurology follow-up for healthy children presenting with new onset unprovoked seizure(s).

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.